Sensitivity of bone remodeling markers in elderly male patients chronically treated with glucocorticoids

Journal of Endocrinological Investigation

Volumn 22, Issue 10 SUPPL. 1, 1999, Pages 79-80

  Manelli, F ^a   Bossoni, S ^a   Carpinteri, R ^a   Bugari, G ^c   Panteghini, M ^b   Romanelli, G ^a   Giustina, A ^a,d  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Spedali Civili of Brescia   (Italy)

^c Spedali Civili   (Italy)

^d Endocrine Section   (Italy)

Author keywords

Bone remodeling markers; Glucocorticoids; Osteopenia

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; GLUCOCORTICOID; HYDROXYPROLINE; OSTEOCALCIN; PREDNISOLONE; PYRIDINE DERIVATIVE;

ADULT; AGING; ARTICLE; BLOOD; BONE; BONE REMODELING; DRUG EFFECT; ENZYMOLOGY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TIME; URINE;

ADULT; AGING; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; GLUCOCORTICOIDS; HUMANS; HYDROXYPROLINE; MALE; MIDDLE AGED; OSTEOCALCIN; PREDNISOLONE; PYRIDINES; TIME FACTORS;

EID: 0033253837     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Reid I.R. Glucocorticoid osteoporsis: mechanisms and management. Eur. J. Endocrinol. 1997, 137: 209-217.
2. Luckert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 1990, 112: 352-364.
3. Suzuki Y., Ichikewa Y., Saito E., Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983, 32: 151-156.
4. Ekenstam E., Stalenheim G., Hallgren R. The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 1988, 37: 141-144.
5. Lems W.F., Gerrits M.I., Jacobs J.W.G., Vanvugt R.M., Vanrijn H.J.M., Bijlsma J.W.J. Changes in markers of bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann. Rheum. Dis. 1996, 62: 379-383.
6. Reid I.R., Chapman G.E., Fraser T.R.C. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J. Clin. Endocrinol. Metab. 1996, 62: 379-383.
7. Bomefalk E., Dahalen I., Michaelsson K, Ljunggren O., Ljunghall S. Age-dependend effect of oral glucocorticoids on markers of bone resorption in patients with acute asthma. Calcif. Tissue Int 1998, 63: 9-13.
8. Giustina A., Bussi A.R., Jacobello C., Wehrenberg W.B. Effect of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 1995, 80: 122-128.